Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573761
Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth on Bone FormationIstanbul Saglik Bilimleri UniversityEnrolling By Invitation
NCT07573761Enrolling By Invitation
—
Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth...Istanbul Saglik Bilimleri...
NCT07574346
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People's HospitalNot Yet RecruitingEarly Phase 1
NCT07574346Not Yet Recruiting
Early Phase 1
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People'...
NCT07574034
A Single Patient Study of Sapropterin for Multisystem Smooth Muscle Dysfunction SyndromeGregor AndelfingerNot Yet RecruitingNot Applicable
NCT07574034Not Yet Recruiting
Not Applicable
A Single Patient Study of Sapropterin for Multisystem Smooth Muscle Dysfunction...Gregor Andelfinger
NCT07572994
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain SyndromeCairo UniversityNot Yet RecruitingNot Applicable
NCT07572994Not Yet Recruiting
Not Applicable
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatm...Cairo University
NCT07572240
A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy IndividualsRousselot BVBANot Yet RecruitingNot Applicable
NCT07572240Not Yet Recruiting
Not Applicable
A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect o...Rousselot BVBA
NCT07573514
Patients With Primary Biliary CholangitisFondazione Policlinico Universitario Agostino Gemelli IRCCSActive Not RecruitingNot Applicable
NCT07573514Active Not Recruiting
Not Applicable
Patients With Primary Biliary CholangitisFondazione Policlinico Un...
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07572357
Clinical Evaluation of the RH210 Hearing AidGlobal Edge Medtech ConsultingNot Yet RecruitingNot Applicable
NCT07572357Not Yet Recruiting
Not Applicable
Clinical Evaluation of the RH210 Hearing AidGlobal Edge Medtech Consu...
NCT07572409
Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory StudymanxiaxiaRecruitingNot Applicable
NCT07572409Recruiting
Not Applicable
Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Singl...manxiaxia
NCT07572292
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine PositionVrije Universiteit BrusselNot Yet RecruitingNot Applicable
NCT07572292Not Yet Recruiting
Not Applicable
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine Po...Vrije Universiteit Brusse...
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07573007
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and ComplicationsMarmara University Pendik Training and Research HospitalNot Yet Recruiting
NCT07573007Not Yet Recruiting
—
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and Comp...Marmara University Pendik...
NCT07573501
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates Working Memory of Patients With Post-stroke Cognitive ImpairmentKe Dong, MDNot Yet RecruitingNot Applicable
NCT07573501Not Yet Recruiting
Not Applicable
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates...Ke Dong, MD
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572045
Promoting Interventions for Climate Change to Upscale Resilience in District BadinDr Jai Kumar DasNot Yet RecruitingNot Applicable
NCT07572045Not Yet Recruiting
Not Applicable
Promoting Interventions for Climate Change to Upscale Resilience in District Bad...Dr Jai Kumar Das
NCT07574385
Sciatic Nerve Block With ALX006 in Subjects Undergoing BunionectomyRebel Medicine IncRecruitingPhase 2
NCT07574385Recruiting
Phase 2
Sciatic Nerve Block With ALX006 in Subjects Undergoing BunionectomyRebel Medicine Inc
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07572513
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue UniversityRecruitingNot Applicable
NCT07572513Recruiting
Not Applicable
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue University
Result Breakdown
Not yet recruiting13 (65%)
Recruiting5 (25%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable13 (65%)
Not Specified3 (15%)
Phase 22 (10%)
Early Phase 11 (5%)
Phase 11 (5%)